HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Brazil
BR112022015897-1
Filed on 2022-08-11
BR112022015897-1
Filed on 2022-08-11
Targeted Combination Therapy
Japan
2019-555879
Filed on 2018-04-11
2019-555879
Filed on 2018-04-11
Targeted Combination Therapy
Israel
269986
Filed on 2018-04-11
269986
Filed on 2018-04-11
Targeted Combination Therapy
European Patent
18783979.0
Filed on 2018-04-11
18783979.0
Filed on 2018-04-11
Targeted Combination Therapy
China
201880038534.X
Filed on 2018-04-11
201880038534.X
Filed on 2018-04-11
Targeted Combination Therapy
Canada
3059882
Filed on 2018-04-11
3059882
Filed on 2018-04-11
Targeted Combination Therapy
Brazil
BR112019021476-3
Filed on 2018-04-11
BR112019021476-3
Filed on 2018-04-11
Targeted Combination Therapy
Australia
2018251788
Filed on 2018-04-11
2018251788
Filed on 2018-04-11
Antisense Oligos That Block Cancer Cell Migration And Invasion
US Application 17/792,507
Filed on 2022-07-13
Filed on 2022-07-13
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
US Application 17/802,464
Filed on 2022-08-25
Filed on 2022-08-25